# reload+after+2024-01-21 10:27:07.257253
phone§(212) 593-4383
longBusinessSummary§Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
maxAge§86400
priceHint§2
yield§0.0
totalAssets§17391856
navPrice§57.59655
currency§USD
category§Health
ytdReturn§-0.0062264
beta3Year§0.63
fundFamily§Virtus
fundInceptionDate§1418688000
legalType§Exchange Traded Fund
threeYearAverageReturn§0.0253702
fiveYearAverageReturn§0.0959718
exchange§PCX
quoteType§ETF
shortName§Virtus LifeSci Biotech Products
longName§Virtus LifeSci Biotech Products ETF
firstTradeDateEpochUtc§1418826600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a74bd30e-1680-37c7-a057-365f82d805f4
messageBoardId§finmb_274653437
gmtOffSetMilliseconds§-18000000
trailingPegRatio§None
